Last reviewed · How we verify

NCT05715866

Non-invasive Stimulation Through Nesa and Therapeutic Exercise on Sleep Disturbances on Alzheimer's Disease Patients.

Completed NA Last updated 8 February 2023
What this trial tests

NA trial testing non-invasive neuromodulation through the Nesa device in Alzheimer Disease in 30 participants. Completed in 22 August 2022.

Timeline
7 December 2021
Primary endpoint
17 June 2022
22 August 2022

Quick facts

Lead sponsorUniversidad de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date7 December 2021
Primary completion17 June 2022
Estimated completion22 August 2022
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Murcia — full company profile →

Who can join

Eligibility, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to know the effectiveness of an adapted therapeutic exercise program and its comparison with non-invasive neuromodulation through the NESA device, and both treatments with a control group, to improve sleep disturbances and cognitive function in patients with dementia, and improves the quality of life of their caregivers.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.
    Morrone CD, Raghuraman R, Hussaini SA, Yu WH. · · 2023 · cited 40× · PMID 37085942 · DOI 10.1186/s13024-023-00617-4
  2. Improving Sleep Quality, Daytime Sleepiness, and Cognitive Function in Patients with Dementia by Therapeutic Exercise and NESA Neuromodulation: A Multicenter Clinical Trial.
    Teruel-Hernández E, López-Pina JA, Souto-Camba S, Báez-Suárez A, et al · · 2023 · cited 11× · PMID 37947583 · DOI 10.3390/ijerph20217027
  3. The Potential for Neuromodulation in the Treatment of Alzheimer's Disease: A Review of Clinical Trials.
    Jones T, Shalom M, Chalamgari A, Gold J, et al · · 2025 · PMID 40599507 · DOI 10.7759/cureus.85156

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

Other Universidad de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing